Cite
Wu C, Zhu J, King A, et al. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer. Cancer Commun (Lond). 2021;41(12):1387-1397doi: 10.1002/cac2.12205.
Wu, C., Zhu, J., King, A., Tong, X., Lu, Q., Park, J. Y., Wang, L., Gao, G., Deng, H. W., Yang, Y., Knudsen, K. E., Rebbeck, T. R., Long, J., Zheng, W., Pan, W., Conti, D. V., Haiman, C. A., & Wu, L. (2021). Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer. Cancer communications (London, England), 41(12), 1387-1397. https://doi.org/10.1002/cac2.12205
Wu, Chong, et al. "Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer." Cancer communications (London, England) vol. 41,12 (2021): 1387-1397. doi: https://doi.org/10.1002/cac2.12205
Wu C, Zhu J, King A, Tong X, Lu Q, Park JY, Wang L, Gao G, Deng HW, Yang Y, Knudsen KE, Rebbeck TR, Long J, Zheng W, Pan W, Conti DV, Haiman CA, Wu L. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer. Cancer Commun (Lond). 2021 Dec;41(12):1387-1397. doi: 10.1002/cac2.12205. Epub 2021 Sep 14. PMID: 34520132; PMCID: PMC8696216.
Copy
Download .nbib